1National Comprehensive Cancer Network, Plymouth Meeting, Pennsylvania.
2The University of Texas MD Anderson Cancer Center, Houston, Texas.
J Natl Compr Canc Netw. 2021 Apr 1;19(4):378-384. doi: 10.6004/jnccn.2021.7005. Print 2021 Apr.
The 21st Century Cures Act (Cures Act), signed into law in 2016, was designed to advance new therapies by modernizing clinical trials, funding research initiatives, and accelerating the development and use of health information technology. To analyze the current issues in cancer care related to the implementation and impact of the Cures Act, NCCN convened a multistakeholder working group. Participants discussed the legislation's impact on the oncology community since enactment and identified the remaining gaps and challenges as experienced by stakeholders. In June 2020, the policy recommendations of the working group were presented at the virtual NCCN Policy Summit: Accelerating Advances in Cancer Care Research: A Lookback at the 21st Century Cures Act in 2020. The summit consisted of informative discussions and a multistakeholder panel to explore the recommendations and the future of the Cures Act. This article explores identified policy recommendations from the NCCN Working Group and the NCCN Policy Summit, and analyzes opportunities to advance innovative cancer care and patient access to data.
21 世纪治愈法案（Cures Act）于 2016 年签署成为法律，旨在通过使临床试验现代化、为研究计划提供资金以及加速健康信息技术的开发和使用来推进新疗法。为了分析与 Cures Act 实施和影响相关的癌症护理方面的当前问题，NCCN 召集了一个多方利益相关者工作组。与会者讨论了自该法案颁布以来对肿瘤学界的影响，并确定了利益相关者所经历的剩余差距和挑战。2020 年 6 月，工作组的政策建议在虚拟 NCCN 政策峰会：加速癌症护理研究进展：回顾 2020 年的 21 世纪治愈法案上提出。峰会由内容丰富的讨论和多方利益相关者小组组成，旨在探讨建议和 Cures Act 的未来。本文探讨了 NCCN 工作组和 NCCN 政策峰会确定的政策建议，并分析了推进创新癌症护理和患者获取数据的机会。
